Palforzia
Product Images NDC 71881-113

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Palforzia (NDC 71881-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aimmune Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Kit Blister Pack)

Principal Display Panel (Kit Blister Pack)
This appears to be a product description, containing information about a medication for peanut allergies. The product is called Palforzia, and is a powder for oral consumption. The description outlines the initial dose escalation process, as well as precautions and instructions for administration. The text also warns against swallowing capsules and inhaling the powder.*
FDA Label Image

Principal Display Panel (Three 1 mg Capsule Dose Pack)

FDA Label Image

Principal Display Panel (Six 1 mg Capsule Dose Pack)

Principal Display Panel (Six 1 mg Capsule Dose Pack)
The text is not available.*
FDA Label Image

Principal Display Panel (Kit Dose Pack)

Principal Display Panel (Kit Dose Pack)
This is a medication guide for a product called "Storages efigete st 210°C". The guide includes instructions on the daily dose pack, which contains powder for oral administration. It warns of the presence of peanut allergen powder and offers dosage information, as well as a caution to keep out of reach of children. However, the results contain many errors, making some of the text illegible and difficult to understand.*
FDA Label Image

Principal Display Panel (One 20 mg Capsule Dose Pack)

FDA Label Image

Principal Display Panel (Two 20 mg Capsule Dose Pack)

FDA Label Image

Principal Display Panel (Four 20 mg Capsule Dose Pack)

FDA Label Image

Principal Display Panel (Kit Dose Pack)

Principal Display Panel (Kit Dose Pack)
This is a description of a medication called "Palfozia" in powder form for oral administration to treat peanut (Arachis hypogaea) allergies. The daily dose pack contains 120mg. Detailed information is available in the medication guide. Storage should be at room temperature.*
FDA Label Image

Principal Display Panel (Kit Dose Pack)

Principal Display Panel (Kit Dose Pack)
This is a medication label indicating the storage and composition of a powder for oral administration called Palfozia for individuals who are allergic to peanuts. The medication is manufactured by Aimmune Therapeutics in Bisane, CA. The label provides information including the daily dose pack of 160mg and warns the user not to exceed the recommended dosage. The label does not provide usage instructions or indications, and it advises the user to refer to the medication guide for more detailed information.*
FDA Label Image

Principal Display Panel (Two 100 mg Capsule Dose Pack)

FDA Label Image

Principal Display Panel (Kit Dose Pack)

FDA Label Image

Principal Display Panel (300 mg Sachet Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.